Company Overview
- Website
- designpharmaceuticals.com
- Employees
- 4
- Industry
- Materials/Manufacturing
- SIC Code
-
2834 - Pharmaceutical Preparations
Financials & Stats
Revenue
$10B
Recent News & Media
Improving cell-free glycoprotein synthesis by characterizing and enriching native membrane vesicles
- Dec 8, 2024
- pmc.ncbi.nlm.nih.gov
Highly multiplexed bioactivity screening reveals human and microbiota metabolome-GPCRome interactions
- Nov 6, 2024
- pmc.ncbi.nlm.nih.gov
Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites
- Oct 28, 2023
- pmc.ncbi.nlm.nih.gov
Within-host evolution of a gut pathobiont facilitates liver translocation
- Jan 13, 2023
- pmc.ncbi.nlm.nih.gov
Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites
- Oct 28, 2022
- science.org
Lyophilization of premixed COVID‐19 diagnostic RT‐qPCR reactions enables stable long‐term storage at elevated temperature - Hammerling - 2021 - Biotechnology Journal
- May 8, 2021
- onlinelibrary.wiley.com
Company Leadership
Design Pharmaceuticals Inc Industry Tags
Companies Similar to Design Pharmaceuticals Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Design Pharmaceuticals Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 16 | Bethlehem, PA | 2005 | |
| 10M | 28 | New York, NY | 2013 | |
| 10M | Pittsburgh, PA | |||
| 10M | 8 | Houston, TX | 2011 | |
| 10M | 3 | Cary, NC | 2009 |